Patents by Inventor Deborah Louise Lane

Deborah Louise Lane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)
    Publication number: 20180327502
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 15, 2018
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Emma Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • BINDING MEMBERS OF INTERLEUKIN-4 RECEPTOR ALPHA (IL4-Ra)
    Publication number: 20180057596
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g., in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: January 24, 2017
    Publication date: March 1, 2018
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Emma Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • STABLE ANTI-IL-4Ra FORMULATION
    Publication number: 20170281769
    Abstract: The present invention relates to a stable, low viscosity antibody formulation, wherein the formulation comprises a high concentration of anti-IL4R antibody. In some embodiments, the invention relates in general to a stable antibody formulation comprising about 100 mg/mL to about 200 mg/mL of an antibody or fragment thereof that specifically binds human interleukin-4 receptor alpha (hIL-4R?), about 50 mM to about 400 mM of a viscosity modifier; about 0.002% to about 0.2% of a non-ionic surfactant; and a formulation buffer. In some embodiments, the formulation buffer is essentially free of phosphate. In some embodiments, the invention is directed to a container, dosage form and/or kit. In some embodiments, the invention is directed to a method of making and using the stable antibody formulation.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 5, 2017
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane, Katrina Day
  • Methods for binding members of interleukin-4 receptor ? (IL-4R?)
    Patent number: 9587027
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: March 7, 2017
    Assignee: MEDIMMUNE LIMITED
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Emma Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • BINDING MEMBERS FOR INTERLEUKIN-4 RECEPTOR ALPHA (IL-4Ra) - 173
    Publication number: 20150079092
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: September 24, 2014
    Publication date: March 19, 2015
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • Binding members for interleukin-4 receptor alpha (IL-4R?) - 173
    Patent number: 8877189
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: November 4, 2014
    Assignee: MedImmune Limited
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
    Publication number: 20130336978
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: June 6, 2013
    Publication date: December 19, 2013
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
    Publication number: 20120171197
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: December 6, 2011
    Publication date: July 5, 2012
    Applicant: MEDIMMUNE LIMITED
    Inventors: PER-OLOF FREDRIK ERIKSSON, KARIN VON WACHENFELDT, SUZANNE COHEN, CLAIRE LOUISE DOBSON, DEBORAH LOUISE LANE
  • Binding members for interleukin-4 receptor alpha (IL-4R?)-173
    Patent number: 8092804
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: January 10, 2012
    Assignee: MedImmune Limited
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane
  • Binding members for interleukin-4 receptor alpha (IL-4Ra)-173
    Publication number: 20090202568
    Abstract: Binding members, especially antibody molecules, for interleukin (IL)-4 receptor alpha (IL-4R?), and their therapeutic use e.g. in treating or preventing disorders associated with IL-4R?, IL-4 and/or IL-13, examples of which are asthma and COPD.
    Type: Application
    Filed: December 18, 2008
    Publication date: August 13, 2009
    Applicant: AstraZeneca AB
    Inventors: Per-Olof Fredrik Eriksson, Karin Von Wachenfeldt, Suzanne Cohen, Claire Louise Dobson, Deborah Louise Lane